1 The Molecular Biosciences Training Grant (MBTG) Program at the University of Wisconsin-Madison supports 2 and enhances the training of predoctoral students who aspire to become research leaders in the cellular, 3 biochemical, and molecular sciences. The MBTG Program has selected a strong cadre of 97 nationally 4 recognized trainers from 23 different departments to mentor trainees. Trainees are selected each year from an 5 outstanding pool of over 600 training grant-eligible applicants to top-ranked campus Ph.D. programs, including 6 the Integrated Program in Biochemistry, the Cellular and Molecular Biology Program, and the Microbiology 7 Doctoral Training Program. The MBTG Program provides trainees with early and intensive orientation and 8 advising, expanded lab rotation opportunities, and support for intellectual and professional development 9 throughout their entire graduate educations. Interdisciplinary training is promoted by a broad core curriculum 10 and a weekly seminar series. The MBTG Program also provides instruction in appropriate scientific conduct, 11 progress tracking, and one-on-one career advising. In its 40 year history, the MBTG Program has enhanced 12 the training of over 600 graduate students, many of whom have become leaders in academia, industry and 13 government laboratories, and non-profit organizations. We currently have 59 trainees, 32 of whom are 14 supported on training grant funds at any one time. The MBTG Program is directed by a dedicated Steering 15 Committee consisting of six trainers, three trainees, and a program administrator. The Ph.D. programs that 16 contribute students to the MBTG Program receive substantial support from the university in the form of 17 recruiting funds and fellowships for trainees from underrepresented groups. The MBTG Program also receives 18 direct financial and administrative support from the university in recognition of the value of our contributions to 19 maintaining a high-quality, student-focused training mission in the Molecular Biosciences. Over the last decade 20 UW-Madison has been at the forefront of meeting the changing needs of predoctoral trainees by providing 21 expanded breadth and flexibility of training, increased support for diversity across the trainee pool, and 22 enhanced professional development opportunities. MBTG trainees can draw on these resources for individual, 23 intentional, specialized training during their graduate studies while also engaging in rigorous training in 24 research. State-of-the-art facilities for biosciences research on the UW-Madison campus, along with a vision 25 toward the future of the biosciences workforce directly benefit MBTG trainees and trainers. These efforts 26 combine to ensure UW-Madison's continued eminence in bioscience research and training. To continue to 27 meet the increasing demands for the enhanced training offered by the MBTG Program, we request a gradual 28 increase of funded positions from the current 32 to 38 by the year 2020.

Public Health Relevance

Biomedical research promises to improve the quality of life and reduce the cost of healthcare for the people in the U.S. and other countries. This potential can only be realized by achieving an outstanding and diverse pool of highly-trained researchers, which is the direct goal of the MBTG Program.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM007215-41
Application #
9073428
Study Section
Training and Workforce Development Subcommittee - D (TWD)
Program Officer
Gindhart, Joseph G
Project Start
1975-07-01
Project End
2019-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
41
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Biochemistry
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Hoang, Trish T; Tanrikulu, I Caglar; Vatland, Quinn A et al. (2018) A Human Ribonuclease Variant and ERK-Pathway Inhibitors Exhibit Highly Synergistic Toxicity for Cancer Cells. Mol Cancer Ther 17:2622-2632
Garcia-Ruiz, Hernan; Diaz, Arturo; Ahlquist, Paul (2018) Intermolecular RNA Recombination Occurs at Different Frequencies in Alternate Forms of Brome Mosaic Virus RNA Replication Compartments. Viruses 10:
Karlsson, Erik A; Meliopoulos, Victoria A; Tran, Vy et al. (2018) Measuring Influenza Virus Infection Using Bioluminescent Reporter Viruses for In Vivo Imaging and In Vitro Replication Assays. Methods Mol Biol 1836:431-459
Doroshenko, Alexander; Pepperell, Caitlin S; Heffernan, Courtney et al. (2018) Epidemiological and genomic determinants of tuberculosis outbreaks in First Nations communities in Canada. BMC Med 16:128
Umlauf, Benjamin J; Mix, Kalie A; Grosskopf, Vanessa A et al. (2018) Site-Specific Antibody Functionalization Using Tetrazine-Styrene Cycloaddition. Bioconjug Chem 29:1605-1613
Mortimer, Tatum D; Weber, Alexandra M; Pepperell, Caitlin S (2018) Signatures of Selection at Drug Resistance Loci in Mycobacterium tuberculosis. mSystems 3:
Florek, Nicholas W; Campos, Luiza M; Braun, Katarina M et al. (2018) An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children. Vaccine 36:758-764
Tancos, Matthew A; Lowe-Power, Tiffany M; Peritore-Galve, F Christopher et al. (2018) Plant-like bacterial expansins play contrasting roles in two tomato vascular pathogens. Mol Plant Pathol 19:1210-1221
Thomas, Sydney P; Hoang, Trish T; Ressler, Valerie T et al. (2018) Human angiogenin is a potent cytotoxin in the absence of ribonuclease inhibitor. RNA 24:1018-1027
Esquilín-Lebrón, Karla J; Boynton, Tye O; Shimkets, Lawrence J et al. (2018) An orphan MbtH-like protein interacts with multiple nonribosomal peptide synthetases in Myxococcus xanthus DK1622. J Bacteriol :

Showing the most recent 10 out of 673 publications